Myriad Genetics
MYGN
MYGN
191 hedge funds and large institutions have $1.55B invested in Myriad Genetics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 73 increasing their positions, 59 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 198 → 191 (-7)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
191
Holding in Top 10
–
Calls
$2.97M
Puts
$839K
Top Buyers
| 1 | +$24.2M | |
| 2 | +$9.17M | |
| 3 | +$8.57M | |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$7.21M |
| 5 |
Goldman Sachs
New York
|
+$6.12M |
Top Sellers
| 1 | -$8.3M | |
| 2 | -$5.43M | |
| 3 | -$4.49M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.24M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.91M |